Skip to content

Resilient Systems

Insight Sciences

  • About
  • Projects
  • Services
  • Skills
  • Shop
  • Contact
  • Bluesky
  • LinkedIn
  • Tumblr
  • X
  • Pinterest
  • Facebook
  • Instagram

Tag: Idenix Pharmaceuticals

Apple Science Profiles – Vertex Pharmaceuticals

August 27, 2008 by timbatchelder, posted in Cognitive Science, Design UX, Health Informatics, Knowledge Management, Linguistic Search, Metadata Masterdata, Network Science
20111230-NodeXL-Twitter-pfizer network graph
20111230-NodeXL-Twitter-pfizer network graph (Photo credit: Marc_Smith)

Apple – Science – Profiles – Vertex Pharmaceuticals.

Vertex uses Macs.

Related articles
  • Safety Can’t Be an Afterthought (fool.com)
  • Vertex (VRTX) Report Positive Data from Viral Kinetic of ALS-2200 in HCV Patients (streetinsider.com)
  • Big Pharma + Big Failure = Big Punishment (dailyfinance.com)
  • U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts (xconomy.com)
  • Vertex Pharma (VRTX) Reports Statistically Significant Data from KALYDECO Phase 2 (streetinsider.com)
  • Veteran biotech investor talks of new reality (utsandiego.com)
  • Financings Of The Fortnight: Idenix To Forge Ahead On HCV Combo After Novartis’ Departure (invivoblog.blogspot.com)
  • Expert On The Amylin Purchase: ‘I Hate This Deal’ (forbes.com)
  • Surge in biotech deals to unlock big investor profits (news.yahoo.com)
  • Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN) (247wallst.com)

Share this:

  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to print (Opens in new window) Print
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Nextdoor (Opens in new window) Nextdoor
  • Click to share on X (Opens in new window) X
  • Click to share on Bluesky (Opens in new window) Bluesky

Like this:

Like Loading...
Tagged Amylin Pharmaceuticals, Apple, Bristol-Myers Squibb, Clinical trial, Cystic fibrosis, Food and Drug Administration, Gilead Science, Gilead Sciences, Idenix Pharmaceuticals, Motley Fool, NASDAQ, Vertex, Vertex PharmaceuticalsLeave a comment

Cognitive Science Cognitive Science UX Research Cognitive Systems AI Data Governance Design UX Digital health Ethnographic Methods Health Informatics Information Visualization Knowledge Management Linguistic Search Metadata Masterdata Metadata Taxonomy Network Science Regenerative Economy Security & Privacy Sustainable Design Systems Science UX Design

  • Which U.S. imports could be affected most by tariffs on China 
  • China unveils AI eyes for the blind to move independently and safely
  • AI Is Coming for These 2 Jobs, Says Tech Investor  
  • I saved $30 a month by using these portable solar panels in my backyard 
  • This is the future of senior housing

    Facebook

    Facebook
    Proudly powered by WordPress | Theme: Karuna by Automattic.
     

    Loading Comments...
     

    You must be logged in to post a comment.

      %d